These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16475685)

  • 1. Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Toyota H; Kondo S; Kyo S; Mizuguchi J
    Anticancer Res; 2006; 26(1A):99-105. PubMed ID: 16475685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co-operatively induce apoptotic cell death in both sarcoma and myeloma cells.
    Suzuki H; Hotta T; Koyama T; Komagata M; Imakiire A; Yanase N; Yoshimoto T; Mizuguchi J
    Anticancer Res; 2003; 23(4):3247-53. PubMed ID: 12926060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Kazhdan I; Marciniak RA
    Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
    Liu X; Yue P; Khuri FR; Sun SY
    Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
    J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
    Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B
    Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
    J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations.
    Meurette O; Lefeuvre-Orfila L; Rebillard A; Lagadic-Gossmann D; Dimanche-Boitrel MT
    Clin Cancer Res; 2005 Apr; 11(8):3075-83. PubMed ID: 15837763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation.
    Kim M; Park SY; Pai HS; Kim TH; Billiar TR; Seol DW
    Cancer Res; 2004 Jun; 64(12):4078-81. PubMed ID: 15205314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B
    Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines.
    Mikami T; Koyama T; Koyama T; Imakiire A; Yamamoto K; Furuhata M; Toyota H; Mizuguchi J
    Anticancer Res; 2006; 26(2A):1153-60. PubMed ID: 16619517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft.
    Huang X; Lin T; Gu J; Zhang L; Roth JA; Stephens LC; Yu Y; Liu J; Fang B
    Gene Ther; 2002 Oct; 9(20):1379-86. PubMed ID: 12365003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins.
    Mirandola P; Sponzilli I; Gobbi G; Marmiroli S; Rinaldi L; Binazzi R; Piccari GG; Ramazzotti G; Gaboardi GC; Cocco L; Vitale M
    Int J Oncol; 2006 Jan; 28(1):127-33. PubMed ID: 16327988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization to gimatecan-induced apoptosis by tumor necrosis factor-related apoptosis inducing ligand in prostate carcinoma cells.
    Perego P; Ciusani E; Gatti L; Carenini N; Corna E; Zunino F
    Biochem Pharmacol; 2006 Mar; 71(6):791-8. PubMed ID: 16438941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
    Gu J; Andreeff M; Roth JA; Fang B
    Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T; Gu J; Zhang L; Huang X; Stephens LC; Curley SA; Fang B
    Cancer Res; 2002 Jul; 62(13):3620-5. PubMed ID: 12097263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism].
    Tang YX; Chen Y; Gu JF; Qi R; Zou WG; Jiang LL; Liu XY
    Ai Zheng; 2005 May; 24(5):536-42. PubMed ID: 15890093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.